{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:34:02Z","timestamp":1788550442488,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T00:00:00Z","timestamp":1253059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s12032-009-9307-8","type":"journal-article","created":{"date-parts":[[2009,9,14]],"date-time":"2009-09-14T23:18:18Z","timestamp":1252970298000},"page":"919-925","source":"Crossref","is-referenced-by-count":47,"title":["Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy"],"prefix":"10.1007","volume":"27","author":[{"given":"Guang-hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-de","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-qiong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiu-qing","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-bing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-tang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,16]]},"reference":[{"key":"9307_CR1","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","volume":"100","author":"ST Sonis","year":"2004","unstructured":"Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, et al. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100:1995\u20132025.","journal-title":"Cancer"},{"key":"9307_CR2","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/gut.2004.062596","volume":"54","author":"J Andreyev","year":"2005","unstructured":"Andreyev J. Gastrointestinal complications of pelvic radiotherapy: are they of any importance? Gut. 2005;54:1051\u20134.","journal-title":"Gut"},{"key":"9307_CR3","first-page":"357","volume":"13","author":"M Hauer-Jensen","year":"2003","unstructured":"Hauer-Jensen M, Wang J, Denham JW. Bowel injury: current and evolving management strategies. Semin Radiat Oncol. 2003;13:357\u201371.","journal-title":"Semin Radiat Oncol"},{"key":"9307_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-8140(02)00060-9","volume":"63","author":"JW Denham","year":"2002","unstructured":"Denham JW, Hauer-Jensen M. The radiotherapeutic injury\u2014a complex \u201cwound\u201d. Radiother Oncol. 2002;63:129\u201345.","journal-title":"Radiother Oncol"},{"key":"9307_CR5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-4804(02)00096-3","volume":"109","author":"JM Hwang","year":"2003","unstructured":"Hwang JM, Chan DC, Chang TM, Tsao TY, Tsou SS, et al. Effects of oral arginine and glutamine on radiation-induced injury in the rat. J Surg Res. 2003;109:149\u201354.","journal-title":"J Surg Res"},{"key":"9307_CR6","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0024-3205(00)00516-6","volume":"66","author":"\u00dcM T\u00fcrko\u011flu","year":"2000","unstructured":"T\u00fcrko\u011flu \u00dcM, Erbil Y, \u00d6ztezcan S, Olga\u00e7 V, Toker G, et al. The effect of selenium and\/or vitamin E treatments on radiation-induced intestinal injury in rats. Life Sci. 2000;66:1905\u201311.","journal-title":"Life Sci"},{"key":"9307_CR7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0305-7372(03)00133-6","volume":"29","author":"DMF Savarese","year":"2003","unstructured":"Savarese DMF, Savy G, Vahdat L, Wischmeyer PE, Corey B. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev. 2003;29:501\u201313.","journal-title":"Cancer Treat Rev"},{"key":"9307_CR8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0022-3565(25)03380-4","volume":"1","author":"CS Jang","year":"1941","unstructured":"Jang CS. The action of berberine on mammalian hearts. J Pharmacol Exp Ther. 1941;1:178\u201386.","journal-title":"J Pharmacol Exp Ther"},{"key":"9307_CR9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2003.09.002","volume":"203","author":"CL Kuo","year":"2004","unstructured":"Kuo CL, Chi CW, Liu TY. The anti-inflammatory potential of berberine in vitro and vivo. Cancer Lett. 2004;203:127\u201337.","journal-title":"Cancer Lett"},{"key":"9307_CR10","volume-title":"TNM classification of malignant tumours","author":"LH Sobin","year":"1997","unstructured":"Sobin LH, Wittekind C. TNM classification of malignant tumours. 5th ed. New York: Wiley-Liss; 1997.","edition":"5"},{"key":"9307_CR11","unstructured":"International Commission on Radiation Units and Measurements. ICRU report 50: prescribing, recording, and reporting photon beam therapy. Washington, DC: International Commission on Radiation Units and Measurements; 1993."},{"key":"9307_CR12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00066-003-1082-4","volume":"179","author":"G Sanguineti","year":"2003","unstructured":"Sanguineti G, Franzone P, Marcenaro M, Foppiano F, Vitale V. Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma: a randomized study. Strahlenther Onkol. 2003;179:464\u201370.","journal-title":"Strahlenther Onkol"},{"key":"9307_CR13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0167-8140(97)00146-1","volume":"45","author":"PC O\u2019Brien","year":"1997","unstructured":"O\u2019Brien PC, Franklin CI, Dear KB, Hamilton CC, Poulsen M, et al. A phase III doubleblind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis. Radiother Oncol. 1997;45:117\u201323.","journal-title":"Radiother Oncol"},{"key":"9307_CR14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0360-3016(01)01660-1","volume":"51","author":"A Kneebone","year":"2001","unstructured":"Kneebone A, Mameghan H, Bolin T, Berry M, Turner S, et al. The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: a double-blind, randomized trial. Int J Radiat Oncol Biol Phys. 2001;51:628\u201335.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9307_CR15","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1200\/JCO.2000.18.11.2226","volume":"18","author":"MI Koukourakis","year":"2000","unstructured":"Koukourakis MI, Kyrias G, Kakolyris S, Kouroussis C, Frangiadaki C, et al. Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study. J Clin Oncol. 2000;18:2226\u201333.","journal-title":"J Clin Oncol"},{"key":"9307_CR16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00066-003-0970-y","volume":"179","author":"J Kouvaris","year":"2003","unstructured":"Kouvaris J, Kouloulias V, Malas E, Antypas C, Kokakis J, et al. Amifostine as radioprotective agent for the rectal mucosa during irradiation of pelvic tumors: a phase II randomized study using various toxicity scales and rectosigmoidoscopy. Strahlenther Onkol. 2003;179:167\u201374.","journal-title":"Strahlenther Onkol"},{"key":"9307_CR17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00066-004-1226-1","volume":"180","author":"VE Kouloulias","year":"2004","unstructured":"Kouloulias VE, Kouvaris JR, Pissakas G, Kokakis JD, Antypas C, et al. A phase II randomized study of topical intrarectal administration of amifostine for the prevention of acute radiation-induced rectal toxicity. Strahlenther Onkol. 2004;180:557\u201362.","journal-title":"Strahlenther Onkol"},{"key":"9307_CR18","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.ijrobp.2005.05.063","volume":"63","author":"A Hille","year":"2005","unstructured":"Hille A, Schmidberger H, Hermann RM, Christiansen H, Saile B, et al. A phase III randomized, placebo-controlled, double-blind study of misoprostol rectal suppositories to prevent acute radiation proctitis in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2005;63:1488\u201393.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9307_CR19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0360-3016(02)02931-0","volume":"54","author":"PC O\u2019Brien","year":"2002","unstructured":"O\u2019Brien PC, Franklin CI, Poulsen MG, Joseph DJ, Spry NS, et al. Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: longer term follow-up of a phase III trial\u2014Trans-Tasman Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2002;54:442\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9307_CR20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF01658133","volume":"10","author":"M Berthrong","year":"1986","unstructured":"Berthrong M. Pathologic changes secondary to radiation. World J Surg. 1986;10:155\u201370.","journal-title":"World J Surg"},{"key":"9307_CR21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ijrobp.2007.12.001","volume":"70","author":"M Brown","year":"2008","unstructured":"Brown M. What causes the radiation gastrointestinal syndrome? Int J Radiat Oncol Biol Phys. 2008;70:799\u2013800.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9307_CR22","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.3748\/wjg.v13.i22.3043","volume":"13","author":"M Molla","year":"2007","unstructured":"Molla M, Panes J. Radiation-induced intestinal inflammation. World J Gastroenterol. 2007;13:3043\u20136.","journal-title":"World J Gastroenterol"},{"key":"9307_CR23","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0024-3205(03)00435-1","volume":"73","author":"DU Lee","year":"2003","unstructured":"Lee DU, Kang YJ, Park MK, Lee YS, Seo HG, et al. Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-a, iNOS, and IL-12 production in LPS-stimulated macrophages. Life Sci. 2003;73:1401\u201312.","journal-title":"Life Sci"},{"key":"9307_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.phrs.2007.06.003","volume":"56","author":"CH Lee","year":"2007","unstructured":"Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC, et al. Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells. Pharmacol Res. 2007;56:193\u2013201.","journal-title":"Pharmacol Res"},{"key":"9307_CR25","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0006-2952(02)00982-6","volume":"63","author":"BY Kang","year":"2002","unstructured":"Kang BY, Chung SW, Cho D, Kim TS. Involvement of p38 mitogen-activated protein kinase in the induction of interleukin-12 p40 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid. Biochem Pharmacol. 2002;63:1901\u201310.","journal-title":"Biochem Pharmacol"},{"key":"9307_CR26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2567.2003.01673.x","volume":"109","author":"TS Kim","year":"2003","unstructured":"Kim TS, Kang BY, Cho D, Kim SH. Induction of interleukin-12 production in mouse macrophages by berberine, a benzodioxolo-quinolizine alkaloid, deviates CD4+ T cells from a Th2 to a Th1 response. Immunology. 2003;109:407\u201314.","journal-title":"Immunology"},{"key":"9307_CR27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0378-8741(01)00387-7","volume":"79","author":"E Yesilada","year":"2002","unstructured":"Yesilada E, K\u00fcpeli E. Berberis crataegina DC root exhibits potent anti-inflammatory, analgesic and febrifuge effects in mice and rats. J Ethnopharmacol. 2002;79:237\u201348.","journal-title":"J Ethnopharmacol"},{"key":"9307_CR28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1681.2007.04819.x","volume":"35","author":"BJ Zhang","year":"2008","unstructured":"Zhang BJ, Xu D, Guo Y, Ping J, Chen LB, et al. Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors. Clin Exp Pharmacol Physiol. 2008;35:303\u20139.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"9307_CR29","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1248\/bpb.29.1906","volume":"29","author":"A Shirwaikar","year":"2006","unstructured":"Shirwaikar A, Shirwaikar A, Rajendran K, Punitha IS. In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine. Biol Pharm Bull. 2006;29:1906\u201310.","journal-title":"Biol Pharm Bull"},{"key":"9307_CR30","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1745-7254.2006.00368.x","volume":"27","author":"F Li","year":"2006","unstructured":"Li F, Wang HD, Lu DX, Wang YP, Qi RB, et al. Neutral sulfate berberine modulates cytokine secretion and increases survival in endotoxemic mice. Acta Pharmacol Sin. 2006;27:1199\u2013205.","journal-title":"Acta Pharmacol Sin"},{"key":"9307_CR31","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.ejca.2008.07.040","volume":"44","author":"Y Liu","year":"2008","unstructured":"Liu Y, Yu H, Zhang C, Cheng Y, Hu L, et al. Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. Eur J Cancer. 2008;44:2425\u201332.","journal-title":"Eur J Cancer"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9307-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-009-9307-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9307-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T04:33:54Z","timestamp":1739334834000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-009-9307-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,16]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9307"],"URL":"https:\/\/doi.org\/10.1007\/s12032-009-9307-8","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,16]]}}}